Uploaded July 2024 | Updated September 2026, 12 hours ago
Scripps Research scientists found that combining ruxolitinib with checkpoint inhibitors may better fight cancers like Hodgkin lymphoma. Findings in @ScienceMagazine are supported by a phase I trial and preclinical models.
#ScrippsResearch #Cancer #Science #Microbiology #Immunology #Research
Scripps Research scientists found that combining ruxolitinib with checkpoint inhibitors may better fight cancers like Hodgkin lymphoma. Findings in @ScienceMagazine are supported by a phase I trial and preclinical models.
#ScrippsResearch #Cancer #Science #Microbiology #Immunology #Research










